Evidence map›Paper›PMID 22585232›Full record

Trial reportJournal of psychopharmacology (Oxford, England)2012

Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images.

Michael E Ballard, Gillinder Bedi, Harriet de Wit

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of psychopharmacology (Oxford, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Effects of ∆BMC psychiatry · 2020
    Review
  15. Article
  16. Developing a phone-based measure of impairment after acute oral ∆Journal of psychopharmacology (Oxford, England) · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Michael E BallardDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA.
Gillinder Bedi
Harriet de Wit
University of Chicago · USColumbia University · US

Funding

Determinants of Drug Preference in Humans--Administrative SupplementR01DA002812 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1985 to 2024
$10.6M
NEUROPSYCHOPHARMACOLOLGY TRG FOR DRUG ABUSE RESEARCHT32DA007255 · NIDA · UNIVERSITY OF CHICAGO · PI VEZINA, PAUL R · 1991 to 2012
$5.9M
NIDA NIH HHS DA02812NIDA NIH HHS R01 DA002812NIDA NIH HHS T32 DA007255
6 · The paper itself

Abstract

There is growing evidence that drugs of abuse alter processing of emotional information in ways that could be attractive to users. Our recent report that Δ⁹-tetrahydrocannabinol (THC) diminishes amygdalar activation in response to threat-related faces suggests that THC may modify evaluation of emotionally-salient, particularly negative or threatening, stimuli. In this study, we examined the effects of acute THC on evaluation of emotional images. Healthy volunteers received two doses of THC (7.5 and 15 mg; p.o.) and placebo across separate sessions before performing tasks assessing facial emotion recognition and emotional responses to pictures of emotional scenes. THC significantly impaired recognition of facial fear and anger, but it only marginally impaired recognition of sadness and happiness. The drug did not consistently affect ratings of emotional scenes. THC's effects on emotional evaluation were not clearly related to its mood-altering effects. These results support our previous work, and show that THC reduces perception of facial threat. Nevertheless, THC does not appear to positively bias evaluation of emotional stimuli in general.

Indexed as

AdolescentAdultAffective SymptomsCannabinoid Receptor AgonistsChicagoDouble-Blind MethodDronabinolDrug UsersExpressed EmotionFacial ExpressionFemaleHallucinogensHumansMalePhotic StimulationPsychiatric Status Rating ScalesCannabinoid Receptor AgonistsDronabinolHallucinogensReceptor, Cannabinoid, CB1

Identifiers

PMID22585232
PMCPMC3664416
OpenAlexW2121275321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.